The Enterprise Value as of April 2025 (TTM) for Cingulate Inc. (CING) is 6.70M

According to Cingulate Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.70M. This represents a change of 245.25% compared to the average of 1.94M of the last 4 quarters.

Cingulate Inc. (CING) Historical Enterprise Value (quarterly & annually)

How has CING Enterprise Value performed in the past?

The mean historical Enterprise Value of Cingulate Inc. over the last ten years is 23.64M. The current 6.70M Enterprise Value has changed 2.73% with respect to the historical average. Over the past ten years (40 quarters), CING's Enterprise Value was at its highest in in the March 2021 quarter at 51.52M. The Enterprise Value was at its lowest in in the September 2024 quarter at -903510.52.

Cingulate Inc. (CING) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cingulate Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cingulate Inc. (CING) Average Enterprise Value

How has CING Enterprise Value performed in the past?

The current Enterprise Value of Cingulate Inc. (CING) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cingulate Inc. (CING) Enterprise Value vs. Peers

How is CING’s Enterprise Value compared to its peers?

Cingulate Inc.’s Enterprise Value is less than SAB Biotherapeutics, Inc. (0), less than Senti Biosciences, Inc. (12.03M), less than Bellicum Pharmaceuticals, Inc. (115.19M), greater than Hillstream BioPharma, Inc. (-5130674.00), greater than Aerovate Therapeutics, Inc. (1.48M), less than Adagene Inc. (33.77M), greater than Acrivon Therapeutics, Inc. Common Stock (-13184509.00), less than Rezolute, Inc. (15.24M), less than AN2 Therapeutics, Inc. (226.06M), less than Genelux Corporation (16.27M), less than Comera Life Sciences Holdings, Inc. (101.96M), greater than Dyadic International, Inc. (334.59K), less than Monopar Therapeutics Inc. (34.07M), less than Miromatrix Medical Inc. (215.25M), less than Inhibikase Therapeutics, Inc. (90.06M), less than PMV Pharmaceuticals, Inc. (100.48M), less than Anebulo Pharmaceuticals, Inc. (14.32M), less than null (31.84M),

Build a custom stock screener for Cingulate Inc. (CING) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cingulate Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cingulate Inc. (CING) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cingulate Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.